Variant report
Variant | nsv826932 |
---|---|
Chromosome Location | chr14:41897273-41900742 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs79765410 | chr14:41897277-41897278 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs553501643 | chr14:41897282-41897283 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs578078235 | chr14:41897312-41897313 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs192217457 | chr14:41897316-41897317 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs7149000 | chr14:41897318-41897319 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
6 | rs575818371 | chr14:41897334-41897335 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs77284820 | chr14:41897354-41897355 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs182678338 | chr14:41897379-41897380 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs528662499 | chr14:41897420-41897421 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs533540063 | chr14:41897442-41897443 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs555440469 | chr14:41897481-41897482 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs546833514 | chr14:41897483-41897484 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs559010570 | chr14:41897500-41897501 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs553390945 | chr14:41897584-41897585 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs573783930 | chr14:41897620-41897621 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs369691249 | chr14:41897625-41897626 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs567006146 | chr14:41897638-41897639 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs533078292 | chr14:41897667-41897668 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs551063454 | chr14:41897669-41897670 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs569651325 | chr14:41897699-41897700 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs536909488 | chr14:41897734-41897735 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs113465344 | chr14:41897756-41897757 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs186070465 | chr14:41897762-41897763 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs567612406 | chr14:41897774-41897775 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs534801209 | chr14:41897820-41897821 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs1960397 | chr14:41897855-41897856 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
27 | rs1115986 | chr14:41897870-41897871 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs576122336 | chr14:41897871-41897872 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs539143394 | chr14:41897881-41897882 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs557037517 | chr14:41897942-41897943 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs1960398 | chr14:41897981-41897982 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
32 | rs190266675 | chr14:41897983-41897984 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs561239949 | chr14:41897991-41897992 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs573237411 | chr14:41897998-41897999 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs540407124 | chr14:41898014-41898015 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs565160764 | chr14:41898036-41898037 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs532854564 | chr14:41898068-41898069 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs182548071 | chr14:41898076-41898077 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs34426913 | chr14:41898081-41898082 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs576481033 | chr14:41898082-41898083 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs186829549 | chr14:41898246-41898247 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs549039771 | chr14:41898304-41898305 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs567551646 | chr14:41898335-41898336 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs377505879 | chr14:41898416-41898417 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs534944211 | chr14:41898427-41898428 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs546788613 | chr14:41898460-41898461 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs148482746 | chr14:41898464-41898465 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs369235502 | chr14:41898482-41898483 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs557428019 | chr14:41898486-41898487 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs192175536 | chr14:41898502-41898503 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Esophageal cancer | 21851588 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Retinoblastoma | 21504564 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Autism | 22495311 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Melanoma | 18172304 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Oral cancer | 21386901 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Neuroblastoma | 19435921 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Breast cancer | 17899364 | CNVD |
Gastrointestinal stromal cancer | 19259404 | CNVD |
Gastrointestinal stromal cancer | 17535989 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Paraganglioma | 17535989 | CNVD |
Pulmonary chondroma | 17535989 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Chronic myeloid leukemia | 20724749 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Wilms tumour | 21544195 | CNVD |
Burkitt''s lymphoma | 19759907 | CNVD |
Lung cancer | 18438408 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Breast cancer | 21785460 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Prostate cancer | 18632612 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Breast cancer | 21858162 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Cancer | 21183584 | CNVD |
Thyroid cancer | 19470727 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Breast cancer | 21364760 | CNVD |
Schizophrenia | 23813976 | CNVD |
Immune disease | 21076436 | CNVD |
Immune disease | 21042300 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Renal cell carcinoma | 18194544 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Bipolar disorder | 19114987 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr14:41895400-41897400 | Weak transcription | ES-I3 Cell Line | embryonic stem cell |
2 | chr14:41897400-41897800 | Enhancers | HUES6 Cell Line | embryonic stem cell |
3 | chr14:41897400-41898000 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
4 | chr14:41898000-41902400 | Weak transcription | ES-I3 Cell Line | embryonic stem cell |
5 | chr14:41899400-41899800 | Enhancers | iPS DF 6.9 Cell Line | embryonic stem cell |